Jenny Yaohua Xue, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins p21(ras) | 6 | 2023 | 1708 | 0.960 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2024 | 2052 | 0.580 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2024 | 5214 | 0.230 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5635 | 0.220 |
Why?
|
Mutation | 5 | 2024 | 29877 | 0.210 |
Why?
|
Neoplasms | 5 | 2023 | 22019 | 0.190 |
Why?
|
RGS Proteins | 1 | 2021 | 75 | 0.190 |
Why?
|
GTP Phosphohydrolases | 2 | 2021 | 515 | 0.190 |
Why?
|
Guanosine Triphosphate | 1 | 2021 | 316 | 0.180 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 2019 | 56 | 0.170 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2024 | 772 | 0.160 |
Why?
|
Adaptation, Biological | 1 | 2020 | 147 | 0.160 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 256 | 0.150 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2019 | 332 | 0.150 |
Why?
|
Antineoplastic Agents | 4 | 2021 | 13621 | 0.140 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2024 | 3584 | 0.130 |
Why?
|
Mutagenesis | 1 | 2019 | 1233 | 0.120 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13238 | 0.120 |
Why?
|
Quinolines | 1 | 2019 | 758 | 0.110 |
Why?
|
Cisplatin | 1 | 2019 | 1642 | 0.110 |
Why?
|
Cell Line, Tumor | 4 | 2024 | 16871 | 0.100 |
Why?
|
Signal Transduction | 3 | 2023 | 23362 | 0.090 |
Why?
|
Nucleotides | 2 | 2023 | 452 | 0.080 |
Why?
|
Mice, Nude | 3 | 2021 | 3605 | 0.080 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3724 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2803 | 0.080 |
Why?
|
Enzyme Activation | 2 | 2023 | 3604 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5247 | 0.060 |
Why?
|
Lipid Peroxidation | 1 | 2024 | 271 | 0.060 |
Why?
|
Oximes | 1 | 2024 | 306 | 0.050 |
Why?
|
Acetonitriles | 1 | 2021 | 54 | 0.050 |
Why?
|
Pyrimidinones | 1 | 2024 | 383 | 0.050 |
Why?
|
Cell Extracts | 1 | 2021 | 135 | 0.050 |
Why?
|
Melanoma | 1 | 2019 | 5692 | 0.050 |
Why?
|
Mice | 6 | 2024 | 81138 | 0.040 |
Why?
|
Hydrolysis | 1 | 2021 | 665 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2023 | 1792 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 616 | 0.040 |
Why?
|
Pyridones | 1 | 2024 | 787 | 0.040 |
Why?
|
Autocrine Communication | 1 | 2019 | 169 | 0.040 |
Why?
|
Imidazoles | 1 | 2024 | 1175 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 642 | 0.040 |
Why?
|
Nucleotidyltransferases | 1 | 2019 | 243 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2021 | 566 | 0.040 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2019 | 491 | 0.030 |
Why?
|
Cell Division | 1 | 2023 | 4463 | 0.030 |
Why?
|
Animals | 6 | 2024 | 167838 | 0.030 |
Why?
|
Humans | 9 | 2024 | 759255 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1619 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1483 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 943 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1886 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2024 | 3106 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4608 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6131 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5783 | 0.020 |
Why?
|
Piperazines | 1 | 2021 | 2517 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2875 | 0.020 |
Why?
|
Pyrimidines | 1 | 2021 | 2996 | 0.020 |
Why?
|
DNA Damage | 1 | 2019 | 2442 | 0.020 |
Why?
|
Cell Survival | 1 | 2019 | 5796 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15636 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9528 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12800 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2021 | 7851 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8055 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10440 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8491 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9492 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41247 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29561 | 0.010 |
Why?
|
Female | 2 | 2021 | 390240 | 0.010 |
Why?
|